A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

Robert H. Lustig,Frank L. Greenway,Pedro Velasquez-Mieyer,D Heimburger,Donald Schumacher,Diane Smith,W Smith,N. Soler,Warsi G,W. Berg,Maloney J,J Benedetto,Zhu W,J. Hohneker

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

2006

Robert H. Lustig
Frank L. Greenway
Pedro Velasquez-Mieyer
D Heimburger
Donald Schumacher
Diane Smith
W Smith
N. Soler
Warsi G
W. Berg
Maloney J
J Benedetto
Zhu W
J. Hohneker

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

Keywords:

Internal medicine
Insulin
Clinical trial
Endocrinology
Diabetes mellitus
Placebo
Octreotide
Medicine
Anti-Obesity Agents
Weight loss
Pancreatic hormone
Skin fold
weight change
Body mass index
Obesity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations